Sinco Pharmaceuticals Holdings Limited (6833.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap323.19M
Enterprise Value132.13M
P/E Ratio6.44
PEG Ratio-0.24
Price/Sales Ratio0.1
Price/Book Ratio0.27
Enterprise/Revenue-0.03
Enterprise/EBITDA-0.65

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.04

Income Statement

Revenue2.08B
Revenue/Share0.95
Gross Profit222.09M
EBITDA99.83M
Net Income34.85M
Diluted EPS0.02

Balance Sheet

Total Cash369.41M
Total Cash/Share0.18
Total Debt116.76M
Total Debt/Equity0.16
Current Ratio1.16
Book Value Per Share0.35

Price History

52-Week Change-43.72
52-Week High0.23
52-Week Low0.1
Moving Average 50 Days0.14
Moving Average 200 Days0.17

Statistics

Average Volume93,375
Shares Outstanding2.03B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield1.49
Payout Ratio0.1
Last Split FactorN/A
Last Split DateN/A
AD